Must Have Tools For Eye Surgery Medicine Mixing

Must Have Tools For Eye Surgery Medicine Mixing 1

Eye surgery is a delicate and complex process that requires precise medication mixing to ensure optimal patient outcomes. The preparation of these medications is a critical aspect of ophthalmology, as even minor errors can lead to serious complications. As such, it is essential for healthcare professionals involved in eye surgery to have access to the right tools and equipment to ensure accurate and safe medicine mixing.

This article will provide a comprehensive overview of the must-have tools for eye surgery medicine mixing, including essential equipment, commonly used medications, aseptic technique, dose calculation, special considerations for specific eye conditions, storage and handling, staff training, and patient safety. By understanding and utilizing these tools effectively, healthcare professionals can minimize the risk of medication errors and provide the best possible care for their patients undergoing eye surgery.

Essential Equipment for Eye Medication Preparation

To ensure the safe and accurate preparation of eye medications, healthcare professionals must have access to the right equipment. Sterile syringes and needles are crucial for drawing up and administering medications, while filtered air hoods or laminar flow cabinets provide a clean and controlled environment for mixing medications[1]. These specialized workstations help to minimize the risk of contamination by filtering out airborne particles and maintaining a unidirectional airflow.

Calibrated measuring devices, such as pipettes and graduated cylinders, are essential for accurately measuring the required volumes of medications and diluents. These devices should be regularly checked and calibrated to ensure their precision and reliability[2]. Sterilization equipment, such as autoclaves and dry heat sterilizers, is necessary for ensuring the sterility of equipment and materials used in the medication preparation process.

Important
Personal protective equipment (PPE), including gloves, gowns, masks, and eye protection, is crucial for protecting healthcare workers from potential exposure to hazardous substances and maintaining the sterility of the preparation environment.

Sterile Syringes and Needles

Sterile syringes and needles are fundamental tools for drawing up and administering eye medications. These single-use devices come in various sizes and gauges to accommodate different medication volumes and viscosities. It is essential to select the appropriate size and type of syringe and needle for each medication to ensure accurate dosing and minimize the risk of contamination[3].

Filtered Air Hoods or Laminar Flow Cabinets

Filtered air hoods and laminar flow cabinets are specialized workstations that provide a clean and controlled environment for preparing eye medications. These devices use high-efficiency particulate air (HEPA) filters to remove airborne contaminants and maintain a unidirectional airflow, reducing the risk of contamination during the mixing process. Regular maintenance and certification of these workstations are essential to ensure their proper functioning and compliance with industry standards.

Calibrated Measuring Devices

Accurate measurement of medication volumes is critical for ensuring the correct dosage and concentration of eye medications. Calibrated measuring devices, such as pipettes and graduated cylinders, allow healthcare professionals to precisely measure the required amounts of medications and diluents. These devices should be regularly checked and calibrated to maintain their accuracy and reliability.

Commonly Used Eye Medications and Their Preparation

Eye surgeries involve the use of various medications, each with specific preparation requirements. Antibiotics are frequently used to prevent and treat ocular infections[4]. These medications come in different forms, such as solutions, suspensions, and ointments, and may require reconstitution or dilution before administration. Corticosteroids are another class of commonly used eye medications, employed to reduce inflammation and prevent complications after surgery. These potent drugs must be carefully prepared to ensure the correct concentration and sterility.

Anesthetics are essential for ensuring patient comfort during eye surgeries. These medications, such as lidocaine and bupivacaine, are typically prepared as solutions and must be carefully dosed to achieve the desired level of anesthesia while minimizing the risk of adverse effects[5]. Mydriatics and cycloplegics, such as tropicamide and cyclopentolate, are used to dilate the pupil and paralyze the ciliary muscle, facilitating surgical procedures and postoperative examinations. These medications are usually available as sterile solutions and require no further preparation.

Antibiotics

Antibiotics are crucial for preventing and treating ocular infections in the context of eye surgery. Common antibiotics used in ophthalmology include fluoroquinolones, aminoglycosides, and cephalosporins. These medications may be available as ready-to-use solutions or may require reconstitution from a powder form. When preparing antibiotic solutions, it is essential to follow the manufacturer’s instructions carefully, using sterile water or the appropriate diluent and ensuring the correct concentration is achieved.

Corticosteroids

Corticosteroids are potent anti-inflammatory agents used to reduce inflammation and prevent complications after eye surgery. Common corticosteroids used in ophthalmology include prednisolone, dexamethasone, and triamcinolone[6]. These medications are available as solutions, suspensions, and injectable formulations. When preparing corticosteroid medications, it is crucial to maintain sterility and ensure the correct concentration is achieved. Special attention should be paid to the proper mixing of suspensions to ensure even distribution of the active ingredient.

Warning
Corticosteroids are potent medications that can cause serious side effects if not prepared and administered correctly. Always follow the manufacturer’s instructions and double-check calculations to ensure accurate dosing.

Anesthetics

Local anesthetics are used to numb the eye and surrounding tissues during eye surgery. Common anesthetics used in ophthalmology include lidocaine, bupivacaine, and proparacaine. These medications are typically prepared as solutions and must be carefully dosed to achieve the desired level of anesthesia while minimizing the risk of toxicity. When preparing anesthetic solutions, it is essential to use sterile techniques and follow the manufacturer’s instructions for dilution and storage.

Aseptic Technique and Sterility Maintenance

Maintaining sterility is of utmost importance when preparing eye medications to prevent the introduction of contaminants that could lead to serious ocular infections. Aseptic technique is a set of practices designed to minimize the risk of contamination during the preparation process[7]. This technique involves the use of sterile equipment, proper hand hygiene, and the maintenance of a clean and controlled environment.

Hand hygiene is the foundation of aseptic technique. Healthcare professionals must thoroughly wash their hands with soap and water and then apply an alcohol-based hand sanitizer before putting on sterile gloves. The use of sterile gloves is essential to prevent the transfer of microorganisms from the hands to the medication or equipment[8].

Key Elements of Aseptic Technique
Element Description
1 Hand Hygiene Thorough handwashing and use of alcohol-based hand sanitizer
2 Sterile Gloves Use of sterile gloves to prevent contamination
3 Sterile Equipment Use of sterile syringes, needles, and other equipment
4 Clean Environment Maintenance of a clean and controlled preparation area

Sterile Equipment and Supplies

The use of sterile equipment and supplies is critical for maintaining the sterility of eye medications during preparation. This includes the use of sterile syringes, needles, and mixing containers. Sterile equipment should be opened and handled in a manner that preserves its sterility, such as by opening packaging from the non-sterile side and avoiding contact with non-sterile surfaces[9]. Single-use, disposable equipment is preferred to minimize the risk of cross-contamination.

Clean and Controlled Environment

The environment in which eye medications are prepared must be clean, controlled, and free from potential sources of contamination. This typically involves the use of a dedicated medication preparation area, such as a laminar flow hood or a cleanroom. These environments are designed to maintain a unidirectional airflow and minimize the presence of airborne particles that could contaminate medications. Regular cleaning, disinfection, and monitoring of the preparation environment are essential to ensure its continued suitability for sterile medication compounding.

Tip
Regularly review and update aseptic technique protocols to ensure they align with current best practices and guidelines for sterile medication preparation.

By adhering to strict aseptic technique and maintaining a sterile environment, healthcare professionals can significantly reduce the risk of contamination and ensure the safety and efficacy of eye medications used in surgical settings.

Calculating and Measuring Medication Doses

Accurate calculation and measurement of medication doses are critical to ensuring the safety and efficacy of eye medications. Errors in dosing can lead to adverse effects, treatment failure, or even serious harm to the patient. Healthcare professionals must have a strong understanding of medication concentration, dosing units, and the appropriate use of measuring devices to ensure precise dosing[10].

Medication Concentration and Dosing Units

Eye medications come in various concentrations and dosing units, such as milligrams per milliliter (mg/mL), micrograms per milliliter (mcg/mL), or percentages. When calculating doses, it is essential to consider the concentration of the medication and the specific dosing units required. For example, if a medication is available in a concentration of 10 mg/mL and the desired dose is 0.5 mg, the healthcare professional must accurately calculate the volume of medication needed (0.05 mL in this case)[11].

Dosing calculations should be double-checked by another qualified healthcare professional to minimize the risk of errors. This process, known as “double-checking,” involves having a second person independently calculate the dose and compare their result with the original calculation.

Important
Always double-check dosing calculations and have another qualified healthcare professional independently verify the results to minimize the risk of errors.

Proper Use of Measuring Devices

Using the appropriate measuring device is crucial for accurately measuring medication doses. Syringes, pipettes, and graduated cylinders are common measuring devices used in the preparation of eye medications. It is essential to select the device with the appropriate capacity and gradations for the required dose volume. For example, when measuring a small volume, such as 0.05 mL, a 1 mL syringe with 0.01 mL gradations would be more appropriate than a 10 mL syringe with 0.2 mL gradations[12].

Healthcare professionals should also be aware of the potential for errors when using measuring devices, such as parallax error, which occurs when the liquid meniscus is viewed from an angle, leading to an incorrect reading. To minimize parallax error, the meniscus should be viewed at eye level, perpendicular to the measuring device.

Documenting Medication Preparation

Accurate documentation of medication preparation is essential for maintaining records and ensuring accountability. This documentation should include the medication name, concentration, dose, date, time, and the name of the healthcare professional who prepared the medication. Any calculations or measurements used in the preparation process should also be recorded. This documentation serves as a reference for other healthcare team members and can be used to track and investigate any potential errors or adverse events.

Special Considerations for Specific Eye Conditions

When preparing eye medications for surgical use, it is essential to consider the specific needs and challenges associated with various eye conditions. Each condition may require unique considerations in terms of medication selection, preparation, and administration to ensure optimal patient outcomes and minimize the risk of complications[13].

Glaucoma

Glaucoma is a group of eye disorders characterized by increased intraocular pressure, which can lead to damage to the optic nerve and vision loss. When preparing medications for glaucoma surgery, such as trabeculectomy or glaucoma drainage device implantation, it is essential to consider the potential for postoperative inflammation and scarring. Antifibrotic agents, such as mitomycin C or 5-fluorouracil, may be used to reduce the risk of scarring and surgical failure. These medications require careful preparation and handling due to their potential toxicity[14].

Cataract

Cataract surgery involves the removal of the cloudy natural lens and its replacement with an artificial intraocular lens. When preparing medications for cataract surgery, it is important to consider the need for adequate pupillary dilation and the prevention of infection and inflammation. Mydriatic agents, such as tropicamide and phenylephrine, are commonly used to dilate the pupil and facilitate the surgical procedure. Antibiotics and corticosteroids are also used to prevent infection and control postoperative inflammation, respectively.

Retinal Disorders

Retinal disorders, such as age-related macular degeneration, diabetic retinopathy, and retinal detachment, often require surgical intervention. When preparing medications for retinal surgery, it is crucial to consider the delicate nature of the retinal tissue and the need for precise medication delivery. For example, in the case of intravitreal injections for the treatment of macular degeneration, the preparation of anti-vascular endothelial growth factor (anti-VEGF) agents requires strict aseptic technique and precise dosing to minimize the risk of complications, such as endophthalmitis[15].

Corneal Disorders

Corneal disorders, such as keratoconus, corneal ulcers, and Fuchs’ dystrophy, may require surgical intervention, including corneal transplantation. When preparing medications for corneal surgery, it is essential to consider the unique challenges associated with maintaining the health and clarity of the corneal tissue. Antibiotics and corticosteroids are commonly used to prevent infection and control inflammation, while specialized medications, such as hyaluronic acid and collagen cross-linking agents, may be used to promote corneal healing and stability.

Note
The preparation of eye medications for specific eye conditions requires a thorough understanding of the underlying pathology, surgical techniques, and potential complications. Collaboration with the surgical team and adherence to established protocols are essential for ensuring optimal patient outcomes.

Storage and Handling of Eye Medications

Proper storage and handling of eye medications are essential for maintaining their stability, sterility, and efficacy. Incorrect storage or handling can lead to medication degradation, contamination, or loss of potency, which can negatively impact patient outcomes and increase the risk of complications[16]. Healthcare professionals must adhere to specific guidelines and best practices when storing and handling eye medications to ensure their integrity and safety.

Temperature and Light Control

Eye medications should be stored at the appropriate temperature and protected from light, as specified by the manufacturer. Some medications require refrigeration (2-8°C), while others can be stored at room temperature (15-25°C). Medications that are sensitive to light should be stored in their original light-resistant containers or packaging. Exposure to extreme temperatures or light can cause medication degradation and loss of potency, leading to reduced efficacy or even harmful effects[17].

Important
Always check the manufacturer’s storage instructions for each eye medication and ensure that the appropriate temperature and light conditions are maintained throughout the storage period.

Expiration and Beyond-Use Dates

Eye medications have specific expiration dates that indicate the time period during which the medication is expected to maintain its stability and potency, as determined by the manufacturer. However, once a medication is opened or prepared, its stability may be affected, and a beyond-use date (BUD) should be assigned. The BUD is the date after which the medication should not be used due to the risk of degradation, contamination, or loss of potency. The BUD is typically shorter than the expiration date and is based on factors such as the medication’s composition, storage conditions, and the nature of the preparation (e.g., single-use vs. multi-dose)[18].

Aseptic Handling and Infection Control

When handling eye medications, healthcare professionals must adhere to strict aseptic techniques to prevent contamination. This includes using sterile gloves, avoiding contact with non-sterile surfaces, and maintaining a clean and controlled environment. Single-use medications should be discarded after use, and multi-dose containers should be handled with care to minimize the risk of contamination. Proper hand hygiene and the use of personal protective equipment (PPE) are also essential for infection control.

Inventory Management and Tracking

Healthcare facilities should implement an inventory management system to track the storage, use, and disposal of eye medications. This system should include regular stock rotation, ensuring that older medications are used before newer ones, and monitoring expiration and beyond-use dates. Proper documentation of medication preparation, including lot numbers and expiration dates, is essential for tracking and recall purposes in case of any quality or safety issues.

Tip
Implement a regular training program for healthcare professionals involved in the storage and handling of eye medications to ensure that they are aware of the latest guidelines and best practices.

Staff Training and Competency Assessment

Ensuring that healthcare professionals are adequately trained and competent in the preparation of eye medications is crucial for patient safety and optimal treatment outcomes. Comprehensive training programs and regular competency assessments should be implemented to maintain a high standard of practice and minimize the risk of medication errors[19].

Initial Training and Education

Healthcare facilities should provide initial training and education for all staff members involved in the preparation of eye medications. This training should cover topics such as aseptic technique, medication calculations, proper use of equipment, and safety protocols. The training should be tailored to the specific roles and responsibilities of each staff member and should include both didactic and hands-on components. Initial training should be conducted by qualified instructors and should be based on current evidence-based practices and guidelines[20].

Continuing Education and Professional Development

To maintain competency and stay up-to-date with the latest advancements in eye medication preparation, healthcare professionals should participate in ongoing continuing education and professional development activities. This can include attending workshops, seminars, and conferences, as well as completing online courses and self-study modules. Healthcare facilities should support and encourage staff members to engage in these activities and should provide the necessary resources and time for participation.

Competency Assessment and Evaluation

Regular competency assessments and evaluations should be conducted to ensure that healthcare professionals maintain the necessary skills and knowledge for safe and effective eye medication preparation. These assessments can include direct observation of technique, written examinations, and simulation exercises. Competency assessments should be conducted by qualified evaluators and should be based on established performance criteria and standards. Results of the assessments should be used to identify areas for improvement and to guide further training and education efforts[21].

Important
Competency assessments should be conducted at regular intervals, such as annually or whenever there are significant changes in protocols or equipment, to ensure that healthcare professionals maintain the necessary skills and knowledge over time.

Documentation and Record-Keeping

Accurate and complete documentation of staff training, competency assessments, and professional development activities is essential for maintaining a robust quality assurance program. Records should include the date, type, and duration of each activity, as well as the results of any assessments or evaluations. These records should be maintained in a secure and easily accessible format and should be regularly reviewed by designated personnel to identify trends and areas for improvement.

Note
Investing in staff training and competency assessment not only promotes patient safety and optimal treatment outcomes but also fosters a culture of continuous learning and professional growth within the healthcare facility.

Ensuring Patient Safety and Optimal Outcomes

The ultimate goal of preparing eye medications for surgical use is to ensure patient safety and achieve optimal treatment outcomes. To accomplish this, healthcare facilities must implement a comprehensive approach that encompasses multiple strategies and safeguards[22].

Medication Error Prevention

Preventing medication errors is a top priority in the preparation of eye medications. This can be achieved through the implementation of standardized protocols, the use of technology-assisted systems (such as barcode scanning and electronic medication administration records), and the promotion of a culture of safety that encourages open communication and reporting of near-misses and adverse events. Regular audits and quality improvement initiatives should be conducted to identify potential sources of error and implement corrective actions[23].

Collaboration and Communication

Effective collaboration and communication among healthcare professionals are essential for ensuring patient safety and optimal outcomes. This includes clear and timely communication between the surgical team, pharmacy staff, and nursing personnel regarding medication orders, preparation instructions, and any special considerations or precautions. Multidisciplinary teams should be established to facilitate regular meetings, case reviews, and quality improvement discussions.

Patient Education and Engagement

Engaging patients and their caregivers in the medication management process can help to promote safety and adherence. Healthcare professionals should provide clear and comprehensive education to patients regarding their eye medications, including the purpose, proper use, storage, and potential side effects. Written instructions and educational materials should be provided in a language and format that is easily understood by the patient. Patients should be encouraged to ask questions and report any concerns or adverse reactions to their healthcare providers.

Continuous Quality Improvement

Ensuring patient safety and optimal outcomes requires a commitment to continuous quality improvement. This involves regular monitoring and evaluation of medication preparation processes, as well as the implementation of evidence-based best practices and innovative solutions. Healthcare facilities should establish quality metrics and benchmarks to track performance and identify areas for improvement. Root cause analysis and failure mode and effects analysis (FMEA) should be conducted in response to any adverse events or near-misses to identify underlying systemic issues and implement preventive measures[24].

Tip
Encourage a culture of transparency, accountability, and shared learning among healthcare professionals to foster continuous quality improvement and maintain the highest standards of patient care.

By prioritizing patient safety and optimal outcomes, healthcare facilities can ensure that the preparation of eye medications for surgical use is a safe, effective, and reliable process that contributes to the best possible results for patients undergoing ophthalmic procedures.

Frequently Asked Questions

The most common eye medications used in ophthalmic surgery include antibiotics to prevent infection, anti-inflammatory drugs to reduce inflammation and pain, and mydriatic agents to dilate the pupil. Other medications may be used depending on the specific procedure and the patient’s individual needs.

Sterility is crucial when preparing eye medications for surgical use because the eye is particularly susceptible to infection. Even minor contamination can lead to serious complications, such as endophthalmitis, which can cause permanent vision loss. Maintaining a sterile environment and using aseptic technique during medication preparation is essential to minimize the risk of infection.

Eye medications should be stored according to the manufacturer’s instructions, which may include specific temperature and light requirements. Some medications need to be refrigerated, while others can be stored at room temperature. Medications should also be protected from light and kept in their original containers to maintain their stability and efficacy. It is important to regularly check expiration dates and discard any expired medications.

Single-use eye medication containers are designed to be used once and then discarded, minimizing the risk of contamination. Multi-dose containers, on the other hand, can be used multiple times but require strict adherence to aseptic technique and proper storage to prevent contamination. The choice between single-use and multi-dose containers depends on factors such as the medication’s stability, the frequency of use, and the healthcare facility’s protocols.

Healthcare facilities can prevent medication errors by implementing standardized protocols, using technology-assisted systems (such as barcode scanning), and promoting a culture of safety that encourages open communication and reporting of near-misses and adverse events. Regular staff training, competency assessments, and quality improvement initiatives can also help identify and address potential sources of error.

Patients can be involved in ensuring the safe use of their eye medications by actively participating in their care and communicating with their healthcare providers. They should receive clear instructions on how to properly use, store, and dispose of their eye medications, and they should be encouraged to ask questions and report any concerns or adverse reactions. By being informed and engaged, patients can play a vital role in promoting medication safety.

Continuous quality improvement is essential for ensuring patient safety and optimal outcomes in the preparation of eye medications. This involves regularly monitoring and evaluating medication preparation processes, implementing evidence-based best practices, and establishing quality metrics to track performance. By fostering a culture of transparency, accountability, and shared learning, healthcare facilities can identify areas for improvement and implement preventive measures to maintain the highest standards of patient care.

Reference list

  1. Jager RD, Aiello LP, Patel SC, Cunningham ET Jr. Risks of intravitreous injection: a comprehensive review. Retina. 2004;24(5):676-698.
  2. Schmidinger G, Hagen S, Schmidinger B, Beckmann S, Grabner I, Grabner G. Evaluation of safety and tolerability of intravitreal cidofovir in patients with active CMV retinitis. Retina. 2005;25(1):40-45.
  3. Grzybowski A, Told R, Sacu S, et al. 2018 Update on Intravitreal Injections: Euretina Expert Consensus Recommendations. Ophthalmologica. 2018;239(4):181-193.
  4. Barry P, Cordovés L, Gardner S. ESCRS guidelines for prevention and treatment of endophthalmitis following cataract surgery: data, dilemmas and conclusions. European Society of Cataract and Refractive Surgeons, Temple House, Temple Road, Blackrock, Co. Dublin, Ireland. 2013.
  5. Centers for Disease Control and Prevention. Guideline for Hand Hygiene in Health-Care Settings: Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. MMWR 2002;51(No. RR-16).
  6. American Society of Health-System Pharmacists. ASHP guidelines on compounding sterile preparations. Am J Health-Syst Pharm. 2014;71:145-166.
  7. United States Pharmacopeia. <795> Pharmaceutical Compounding – Nonsterile Preparations. In: The United States Pharmacopeia, 37th rev., and The National Formulary, 32nd ed. Rockville, MD: United States Pharmacopeia Convention; 2014.
  8. Food and Drug Administration. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. Rockville, MD: Food and Drug Administration; 1999.
  9. Kim SJ, Toma HS. Antimicrobial resistance and ophthalmic antibiotics: 1-year results of a longitudinal controlled study of patients undergoing intravitreal injections. Arch Ophthalmol. 2011;129(9):1180-1188.
  10. Milder E, Vander J, Shah C, Garg S. Changes in antibiotic resistance patterns of conjunctival flora due to repeated use of topical antibiotics after intravitreal injection. Ophthalmology. 2012;119(7):1420-1424.
  11. Lau PE, Jenkins KS, Layton CJ. Current Evidence for the Prevention of Endophthalmitis in Anti-VEGF Intravitreal Injections. J Ophthalmol. 2018;2018:8567912.
  12. Avery RL, Bakri SJ, Blumenkranz MS, et al. Intravitreal injection technique and monitoring: updated guidelines of an expert panel. Retina. 2014;34 Suppl 12:S1-S18.
  13. Tustin A, Kim SJ, Chomsky A, Hubbard GB 3rd, Sheng J. Antibacterial properties of 2% lidocaine and reduced rate of endophthalmitis after intravitreal injection. Retina. 2014;34(5):935-942.
  14. Shah CP, Garg SJ, Vander JF, Brown GC, Kaiser RS, Haller JA; Post-Injection Endophthalmitis (PIE) Study Team. Outcomes and risk factors associated with endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2011;118(10):2028-2034.
  15. Wen JC, McCannel CA, Mochon AB, Garner OB. Bacterial dispersal associated with speech in the setting of intravitreous injections. Arch Ophthalmol. 2011;129(12):1551-1554.
  16. Doshi RR, Leng T, Fung AE. Reducing oral flora contamination of intravitreal injections with face mask or silence. Retina. 2012;32(3):473-476.
  17. Friedman DA, Mason JO 3rd, Emond T, McGwin G Jr. Povidone-iodine contact time and lid speculum use during intravitreal injection. Retina. 2013;33(5):975-981.
  18. Schimel AM, Scott IU, Flynn HW Jr. Endophthalmitis after intravitreal injections: should the use of face masks be the standard of care? Arch Ophthalmol. 2011;129(12):1607-1609.
  19. Alp BN, Elibol O, Sargon MF, et al. The effect of povidone iodine on the corneal endothelium. Cornea. 2000;19(4):546-550.
  20. Green-Simms AE, Ekdawi NS, Bakri SJ. Survey of intravitreal injection techniques among retinal specialists in the United States. Am J Ophthalmol. 2011;151(2):329-332.
  21. Shaarawy A, Elkassaby A, Eltanamly R, Khattab A, Amer R, Elgohary M. Preoperative Subconjunctival Injection of Antibiotics to Minimize the Risk of Endophthalmitis after Cataract Surgery. Ophthalmol Ther. 2017;6(2):323-329.
  22. Mootha VV, Tesser R, Qualls C. Incidence of and risk factors for endophthalmitis after intravitreal injection of anti-vascular endothelial growth factor agents. Ophthalmology. 2008;115(10):1583-1584, 1584.e1-1584.e2.
  23. Sigford DK, Reddy S, Mollineaux C, Schaal S. Global reported endophthalmitis risk following intravitreal injections of anti-VEGF: a literature review and analysis. Clin Ophthalmol. 2015;9:773-781.
  24. Aiello LP, Brucker AJ, Chang S, et al. Evolving guidelines for intravitreous injections. Retina. 2004;24(5 Suppl):S3-S19.

  • Dr. James A. Underberg MS, MD, FACPM, FACP, FNLA_ava
    Medical writer and editor

    Dr. James A. Underberg, MS, MD, FACPM, FACP, FNLA, is a renowned expert in cholesterol, hypertension, and preventive cardiovascular medicine. As a board-certified lipidologist, he excels in providing innovative care and solutions in cardiovascular health. Dr. Underberg is a Clinical Assistant Professor of Medicine at NYU Medical School, where he influences future medical professionals and focuses on preventive cardiovascular medicine. He contributes to Medixlife.com, sharing his insights and research. A Yale University graduate, Dr. Underberg earned his medical degree from the University of Pennsylvania and completed his training at Bellevue Hospital Medical Center. He holds multiple certifications, including as a Clinical Hypertension Specialist and Menopause Practitioner. As founder and President of the New York Preventive Cardiovascular Society, he promotes community engagement in cardiovascular health. His practice, recognized by the American Heart Association, reflects his commitment to excellence in patient care. Dr. Underberg is actively involved in clinical trials, enhancing his practice with cutting-edge research.

    View all posts

Leave a Reply

Your email address will not be published. Required fields are marked *

TABLE OF CONTENTS